HE4 in comparison with other biomarkers in ovarian cancer diagnostics
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F15%3A10288262" target="_blank" >RIV/00216208:11140/15:10288262 - isvavai.cz</a>
Alternative codes found
RIV/00669806:_____/15:10288262
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
HE4 in comparison with other biomarkers in ovarian cancer diagnostics
Original language description
Ovarian cancer is the leading cause of gynecological cancer death. The first aim of our study was to evaluate if HE4 broadens the possibilities in ovarian cancer diagnostics. The second aim was to evaluate the benefits of each biomarker of our panel. Wecompared the results of following tumor markers: CA 125, HE4, CA 19-9, CEA, TK, TPS, MonoTotal. The total number of females in our study was 266.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FE - Other fields of internal medicine
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Plzeňský lékařský sborník
ISSN
0551-1038
e-ISSN
—
Volume of the periodical
2014
Issue of the periodical within the volume
80
Country of publishing house
CZ - CZECH REPUBLIC
Number of pages
6
Pages from-to
21-26
UT code for WoS article
—
EID of the result in the Scopus database
—